Deadline

Ultragenyx Pharmaceutical Inc. faces a class action lawsuit with an April 6, 2026 deadline for claimants. The suit involves allegations regarding the company’s business practices and disclosures, common in the pharmaceutical sector due to complex regulations and market dynamics. Affected parties should consult legal counsel specializing in class action litigation and securities law to understand their rights and ensure timely filing.